HTG Molecular Diagnostics, Inc. (HTGM)
(Delayed Data from NSDQ)
$2.59 USD
+0.10 (4.02%)
Updated May 3, 2019 04:00 PM ET
After-Market: $2.58 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
HTG Molecular Diagnostics, Inc. [HTGM]
Reports for Purchase
Showing records 41 - 60 ( 90 total )
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
New Autoimmune Profiling Assay Launched; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
2Q19 Financial Results Reported; Reiterate Buy and Lowering PT to $4
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
RUO Assay Menu Expanded with New Platform Compatibility; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
EdgeSeq Reveal Data Analytics Software Updated; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
No-Go Decision Doesn?t Affect Near-Term Revenue; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
1Q19 Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
Illumina Agreement Expanded to Cover More Disease Fields; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
2018 Financial Results Reported; Continued Revenue Base Expansion; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
Precision Diagnostic Partnership Extended; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
New Software Launched for EdgeSeq I/O Panel; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
Preliminary Full-Year 2018 Financial Results; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
French Subsidiary Established; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
European Market Footprint Expanded; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
3Q18 Financial Results Reported; Reiterate Buy and Raise Price Target to $8
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
EdgeSeq Adopted by European Oncology Institute; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
One Step Further Towards a Companion Diagnostic Assay; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
Disease Indication Expansion Within QIAGEN Collaboration; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
Precision Immuno-Oncology Panel Launched; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
2Q18 Financial Results Reported; Continued Top-Line Expansion; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R